Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131846) titled 'Metformin and gut microbiota interaction in newly diagnosed type 2 diabetes' on Sept. 7.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Sir Run Run Hospital, Nanjing Medical University

Condition: Newly diagnosed type 2 diabetes

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-07

Target Sample Size: Metformin intervention group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341895

Published by HT Digital Content Services with permission from Health Daily Digest....